REALM - RANDOMIZED, OBSERVATIONAL STUDY OF ENTECAVIR TO ASSESS LONG-TERM OUTCOMES ASSOCIATED WITH NUCLEOSIDE/NUCLEOTIDE MONOTHERAPY FOR PATIENTS WITH CHRONIC HIV INFECTION Trademark

Trademark Overview

On Tuesday, July 25, 2006, a trademark application was filed for REALM - RANDOMIZED, OBSERVATIONAL STUDY OF ENTECAVIR TO ASSESS LONG-TERM OUTCOMES ASSOCIATED WITH NUCLEOSIDE/NUCLEOTIDE MONOTHERAPY FOR PATIENTS WITH CHRONIC HIV INFECTION with the United States Patent and Trademark Office. The USPTO has given the REALM - RANDOMIZED, OBSERVATIONAL STUDY OF ENTECAVIR TO ASSESS LONG-TERM OUTCOMES ASSOCIATED WITH NUCLEOSIDE/NUCLEOTIDE MONOTHERAPY FOR PATIENTS WITH CHRONIC HIV INFECTION trademark a serial number of 78936658. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, June 21, 2010. This trademark is owned by Bristol-Myers Squibb Company. The REALM - RANDOMIZED, OBSERVATIONAL STUDY OF ENTECAVIR TO ASSESS LONG-TERM OUTCOMES ASSOCIATED WITH NUCLEOSIDE/NUCLEOTIDE MONOTHERAPY FOR PATIENTS WITH CHRONIC HIV INFECTION trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Medical and scientific research, namely, conducting clinical trials and clinical studies relating to pharmaceutical preparations for human use
realm - randomized, observational study of entecavir to assess long-term outcomes associated with nucleoside/nucleotide monotherapy for patients with chronic hiv infection

General Information

Serial Number78936658
Word MarkREALM - RANDOMIZED, OBSERVATIONAL STUDY OF ENTECAVIR TO ASSESS LONG-TERM OUTCOMES ASSOCIATED WITH NUCLEOSIDE/NUCLEOTIDE MONOTHERAPY FOR PATIENTS WITH CHRONIC HIV INFECTION
Filing DateTuesday, July 25, 2006
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, June 21, 2010
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 27, 2007

Trademark Statements

Disclaimer with Predetermined Text"RANDOMIZED, OBSERVATIONAL STUDY OF ENTECAVIR TO ASSESS LONG-TERM OUTCOMES ASSOCIATED WITH NUCLEOSIDE/NUCLEOTIDE MONOTHERAPY FOR PATIENTS WITH CHRONIC HIV INFECTION"
Goods and ServicesMedical and scientific research, namely, conducting clinical trials and clinical studies relating to pharmaceutical preparations for human use

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, July 28, 2006
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameBristol-Myers Squibb Company
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10154
Party NameBristol-Myers Squibb Company
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10154

Trademark Events

Event DateEvent Description
Monday, June 21, 2010ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, June 21, 2010ABANDONMENT - NO USE STATEMENT FILED
Monday, December 28, 2009ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, December 28, 2009TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, October 5, 2009EXTENSION 5 GRANTED
Monday, September 21, 2009EXTENSION 5 FILED
Monday, October 5, 2009CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, September 21, 2009TEAS EXTENSION RECEIVED
Monday, April 13, 2009EXTENSION 4 GRANTED
Monday, April 13, 2009EXTENSION 4 FILED
Monday, April 13, 2009TEAS EXTENSION RECEIVED
Thursday, October 9, 2008EXTENSION 3 GRANTED
Thursday, October 9, 2008EXTENSION 3 FILED
Thursday, October 9, 2008TEAS EXTENSION RECEIVED
Monday, May 5, 2008EXTENSION 2 GRANTED
Monday, May 5, 2008EXTENSION 2 FILED
Monday, May 5, 2008TEAS EXTENSION RECEIVED
Monday, November 5, 2007EXTENSION 1 GRANTED
Monday, November 5, 2007EXTENSION 1 FILED
Monday, November 5, 2007TEAS EXTENSION RECEIVED
Tuesday, May 22, 2007NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 10, 2007ASSIGNED TO EXAMINER
Tuesday, February 27, 2007PUBLISHED FOR OPPOSITION
Wednesday, February 7, 2007NOTICE OF PUBLICATION
Thursday, January 11, 2007LAW OFFICE PUBLICATION REVIEW COMPLETED
Thursday, January 11, 2007ASSIGNED TO LIE
Friday, December 15, 2006APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, December 15, 2006EXAMINER'S AMENDMENT MAILED
Thursday, December 14, 2006EXAMINER'S AMENDMENT ENTERED
Thursday, December 14, 2006EXAMINERS AMENDMENT -WRITTEN
Wednesday, December 13, 2006ASSIGNED TO EXAMINER
Wednesday, August 16, 2006PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Wednesday, August 16, 2006TEAS VOLUNTARY AMENDMENT RECEIVED
Friday, July 28, 2006NEW APPLICATION ENTERED IN TRAM

Related Keywords

nucleotide nucleoside associated monotherapy patients infection chronic outcomes term observational clinical relating pharmaceutical preparations human studies trials research namely conducting